ESC 365 - Are NOACs really better than VKA in the real world? - Current knowledge

ESC Premium Access

Are NOACs really better than VKA in the real world? - Current knowledge

Session: Are NOACs really better than VKA in the real world?

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor B. Lewis (Haifa, IL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Basil S Lewis

Technion - Israel Institute of Technology, Haifa (Israel)

4 presentations

0 follower

3 more presentations in this session

Non-vitamin K oral anticoagulants in comparison to phenprocoumon in geriatric and non-geriatric patients: a retrospective, observational study on 71,000 patients with non-valvular atrial fibrillation

Speaker: Doctor C. Hohmann (Cologne, DE)

Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients presenting myocardial infarction with percutaneous coronary intervention

Speaker: Associate Professor K. Lee (Gwangju, KR)

Access the full session

Are NOACs really better than VKA in the real world?

Speakers: Professor B. Lewis, Doctor C. Hohmann, Doctor M. Esteve Pastor, Associate Professor K. Lee

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources